Redpoint Investment Management Pty Ltd lifted its position in shares of Cigna Holding Co (NYSE:CI) by 87.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,319 shares of the health services provider’s stock after purchasing an additional 18,303 shares during the period. Redpoint Investment Management Pty Ltd’s holdings in Cigna were worth $7,467,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Mascoma Wealth Management LLC boosted its holdings in shares of Cigna by 8.1% in the 4th quarter. Mascoma Wealth Management LLC now owns 709 shares of the health services provider’s stock valued at $135,000 after purchasing an additional 53 shares in the last quarter. Howe & Rusling Inc. lifted its stake in shares of Cigna by 1.3% in the 4th quarter. Howe & Rusling Inc. now owns 4,585 shares of the health services provider’s stock valued at $871,000 after acquiring an additional 61 shares during the last quarter. First Command Bank raised its position in Cigna by 11.8% during the 4th quarter. First Command Bank now owns 636 shares of the health services provider’s stock worth $121,000 after purchasing an additional 67 shares during the last quarter. First Command Financial Services Inc. raised its position in Cigna by 11.8% during the 4th quarter. First Command Financial Services Inc. now owns 636 shares of the health services provider’s stock worth $121,000 after purchasing an additional 67 shares during the last quarter. Finally, First Financial Corp IN raised its position in Cigna by 10.1% during the 4th quarter. First Financial Corp IN now owns 786 shares of the health services provider’s stock worth $150,000 after purchasing an additional 72 shares during the last quarter. 93.44% of the stock is currently owned by institutional investors and hedge funds.

Shares of CI stock opened at $197.87 on Friday. Cigna Holding Co has a 12-month low of $163.02 and a 12-month high of $226.60. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.98 and a current ratio of 0.42. The company has a market capitalization of $48.19 billion, a P/E ratio of 13.91, a P/E/G ratio of 0.93 and a beta of 0.72.

Cigna (NYSE:CI) last issued its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company had revenue of $13.75 billion during the quarter, compared to analysts’ expectations of $11.38 billion. During the same quarter in the prior year, the business posted $1.94 EPS. The company’s revenue for the quarter was up 29.3% compared to the same quarter last year. As a group, equities analysts predict that Cigna Holding Co will post 16.4 EPS for the current year.

In other Cigna news, insider Michael W. Triplett sold 9,148 shares of the stock in a transaction that occurred on Monday, February 11th. The shares were sold at an average price of $181.01, for a total value of $1,655,879.48. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director John Partridge sold 1,000 shares of the stock in a transaction that occurred on Thursday, February 7th. The stock was sold at an average price of $184.43, for a total transaction of $184,430.00. The disclosure for this sale can be found here. Insiders sold 10,349 shares of company stock worth $1,882,688 over the last quarter. Insiders own 1.10% of the company’s stock.

Several research analysts have recently weighed in on CI shares. BMO Capital Markets lifted their price objective on Cigna from $220.00 to $230.00 and gave the stock a “hold” rating in a research report on Friday, November 2nd. Citigroup lifted their price target on Cigna from $243.00 to $249.00 and gave the company a “buy” rating in a research note on Friday, November 2nd. Barclays boosted their target price on Cigna from $228.00 to $235.00 and gave the stock an “overweight” rating in a research note on Friday, November 2nd. Zacks Investment Research restated a “strong-buy” rating and issued a $246.00 target price on shares of Cigna in a research note on Monday, November 12th. Finally, Leerink Swann lifted their price target on shares of Cigna from $250.00 to $260.00 and gave the stock an “outperform” rating in a report on Monday, November 19th. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $229.09.

ILLEGAL ACTIVITY NOTICE: “Redpoint Investment Management Pty Ltd Purchases 18,303 Shares of Cigna Holding Co (CI)” was reported by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.watchlistnews.com/redpoint-investment-management-pty-ltd-purchases-18303-shares-of-cigna-holding-co-ci/2826241.html.

Cigna Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Recommended Story: What is a put option?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Holding Co (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.